Literature DB >> 7000504

Effects of increases in plasma vasopressin concentration on plasma renin activity, blood pressure, heart rate, and plasma corticosteroid concentration in conscious dogs.

S A Malayan, D J Ramsay, L C Keil, I A Reid.   

Abstract

It is known that vasopressin decreases PRA and heart rate and increases blood pressure and plasma corticosteroid concentration. The purpose of this study was to determine the plasma concentration of vasopressin required to produce these effects. Arginine vasopressin was administered iv to five normal conscious dogs as priming injections of 0.1, 0.5, 1.0, 2.5, 5.0, and 10.0 ng/kg, followed by infusions of 0.01, 0.05, 0.1, 0.25, 0.5, and 1.0 ng/kg x min, respectively, for 30 min. These doses produced increases in the plasma vasopressin concentration (+/- SE) of 1.0 +/- 0.8, 2.1 +/- 4.3, 4.3 +/- 1.8, 11.4 +/- 1.0, 19.7 +/- 6.4, and 30.8 +/- 7.8 pg/ml, respectively, from a basal level of 2.7 +/- 0.2 pg/ml. An increase in the plasma vasopressin concentration of 2.1 +/- 0.3 pg/ml suppressed PRA by 19 +/- 5% (P < 0.02); increases of 4.2 +/- 1.8 pg/ml or more suppressed PRA by 34 +/- 12% (P < 0.005). Only the highest dose of vasopressin produced a significant pressor effect (9 +/- 3 mm Hg; P < 0.05) or lowered the heart rate (18 +/- 4 beats/min; P < 0.005). An increase in plasma vasopressin concentration of 19.7 +/- 6.4 pg/ml was required to increase the plasma corticosteroid concentration (1.2 +/- 0.2 to 2.2 +/- 0.4 microgram/dl; P < 0.01); the largest dose of vasopressin increased the plasma corticosteroid concentration from 1.5 +/- 0.1 to 2.4 +/- 0.6 microgram/dl (P < 0.02). Twenty-four-hour water deprivation in the same dogs increased the plasma vasopressin concentration from 2.5 +/- 0.2 to 7.4 +/- 0.6 pg/ml (P < 0.01). Nonhypotensive hemorrhage in another group of dogs increased the plasma vasopressin concentration from 2.5 +/- 0.2 to 47.4 +/- 16.8 pg/ml (P < 0.05). These data indicate that elevations in the plasma vasopressin concentration within the range observed during 24 h of water deprivation and nonhypotensive hemorrhage produced significant decreases in renin secretion and heart rate and elevations in blood pressure and corticosteroid secretion.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000504     DOI: 10.1210/endo-107-6-1899

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

Review 1.  The roles of V1a vasopressin receptors in blood pressure homeostasis: a review of studies on V1a receptor knockout mice.

Authors:  Yoko Fujiwara; Akito Tanoue; Gozoh Tsujimoto; Taka-Aki Koshimizu
Journal:  Clin Exp Nephrol       Date:  2011-11-01       Impact factor: 2.801

Review 2.  The neuroendocrine response to multiple trauma.

Authors:  D S Gann; M P Lilly
Journal:  World J Surg       Date:  1983-01       Impact factor: 3.352

3.  Long-term depressor effects of catecholamine neuronal grafts in the third ventricle of the brain in normotensive rats.

Authors:  R Hashimoto; F Kimura
Journal:  Experientia       Date:  1991-06-15

4.  Neuronostatin acts in brain to biphasically increase mean arterial pressure through sympatho-activation followed by vasopressin secretion: the role of melanocortin receptors.

Authors:  Gina L C Yosten; Alicia T Pate; Willis K Samson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-02-16       Impact factor: 3.619

5.  Ergonovine-induced constrictions of epicardial coronary arteries in conscious dogs: alpha-adrenoceptors are not involved.

Authors:  J Holtz; W Held; O Sommer; G Kühne; E Bassenge
Journal:  Basic Res Cardiol       Date:  1982 May-Jun       Impact factor: 17.165

6.  Comparison of the development of experimental pyelonephritis in homozygous brattleboro diabetes insipidus rats, heterozygous control rats and normal Wistar rats.

Authors:  M Güngör; O Anğ; V Uysal; H Sağduyu; D Inanç; M Anğ; H Koyuncuoğlu
Journal:  Infection       Date:  1985 Mar-Apr       Impact factor: 3.553

7.  Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptor.

Authors:  A T Hirsch; V J Dzau; J A Majzoub; M A Creager
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

8.  Morphometric and neurosecretory changes in supraoptic neurons after D-amphetamine treatment.

Authors:  M L Bentura; M A Lazcano; M C Zahonero; A Toledano
Journal:  J Neural Transm Gen Sect       Date:  1992
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.